two distinct patterns of response to levamisole were noted : patients having higher pretreatment transaminase levels and lower expression of hbcag in the liver showed an early transaminase normalization and anti-hbe seroconversion with therapy , while in patients with less active disease and more diffuse hbcag positivity in pretreatment liver biopsies , longer treatment periods were necessary to achieve these effects .
C0023884
liver
C0193388
liver